Authority cluster
Mechanistic pathways reported in verified publications, separated from clinical inference.
Investigated in mitochondrial membrane, cardiolipin, redox, and organ-specific mitochondrial dysfunction models. Mechanistic records below are organized by their actual experimental system. They do not prove a clinical effect.
Publication records
Verified PubMed record for SS-31: Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice.
Verified PubMed record for SS-31: Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic Potential.
Verified PubMed record for SS-31: SS-31@Fer-1 Alleviates ferroptosis in hypoxia/reoxygenation cardiomyocytes via mitochondrial targeting.
Verified PubMed record for SS-31: Elamipretide(SS-31) Attenuates Idiopathic Pulmonary Fibrosis by Inhibiting the Nrf2-Dependent NLRP3 Inflammasome in Macrophages.
Verified PubMed record for SS-31: Elamipretide (SS-31) treatment attenuates age-associated post-translational modifications of heart proteins.
Verified PubMed record for SS-31: Mitochondrial targeted therapy with elamipretide (MTP-131) as an adjunct to tumor necrosis factor inhibition for traumatic optic neuropathy in the acute setting.